Clinical Trial Update: Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update assesses the safety and efficacy of an early second infusion of axicabtagene ciloleucel guided by ctDNA for relapsed/refractory diffu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Axi-cel (axicabtagene ciloleucel)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Relapsed/Refractory Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING